KZR - Kezar Life Sciences, Inc.
6.94
0.110 1.585%
Share volume: 26,421
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.83
0.11
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-12-2024 | 03-25-2025 | 05-13-2025 | 08-13-2025 | 11-12-2025 | |
| Cash flow financing | 0.000 | 56.000 K | 0.000 | 47.000 K | -1.304 M | -1.269 M | -1.305 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.454 M | -4.759 M | 0.000 | 6.966 M | -4.752 M | -2.667 M | 4.577 M | |
| Net income | -21.658 M | -21.547 M | -20.313 M | -20.218 M | -16.556 M | -13.704 M | -11.227 M | |
| Depreciation | 260.000 K | 261.000 K | 260.000 K | 259.000 K | 251.000 K | 243.000 K | 227.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 20.408 M | 12.216 M | 24.060 M | 23.744 M | 13.742 M | 11.397 M | 15.712 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 18.000 K | 11.000 K | 8.000 K | 0.000 | 0.000 | |
| Cash Change | -2.461 M | -4.756 M | 6.582 M | 6.891 M | -4.747 M | -2.635 M | 4.568 M |